Occlusive therapy in atopic dermatitis: Overview

References

• Goodyear HM, Spowart K, Harper JI. ‘Wet wrap’ dressings in the treatment of atopic dermatitis in children. Br J Dermatol. 1991; 125:604.
   PubMed Web of Science ®Google Scholar
• Nicol NH. Atopic dermatitis: The wet wrap-up. Am J Nurs. 1987; 12:1560–1563.
   Google Scholar
• Bridgman A. The use of wet wrap dressings for eczema. Paediatr Nurs. 1995; 7:24–27.
   PubMedGoogle Scholar
• Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008; 122:812–824.
   PubMed Web of Science ®Google Scholar
• Rajka G, Aly R, Bayles C, Tang Y, Maibach H. The effect of short-term occlusion on the cutaneous flora in atopic dermatitis and psoriasis. Acta Derm Venereol. 1981; 61:150–153.
   PubMed Web of Science ®Google Scholar
• Aly R, Shirley C, Cunico B, Maibach HI. Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol. 1978; 71:378–381.
   PubMed Web of Science ®Google Scholar
• Williams R. The antibacterial-corticosteroid combination. What is the role in atopic dermatitis? Am J Clin Dermatol. 2000; 1:211–215.
   PubMedGoogle Scholar
• Arikawa J, Ishibashi M, Kawashima M, Takagi Y, Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol. 2002; 119:433–9.
   PubMed Web of Science ®Google Scholar
• Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002; 347:1151–1160.
   PubMed Web of Science ®Google Scholar
• Mallon E, Powell S, Bridgman A. ‘Wet wrap’ dressings for the treatment of atopic eczema in the community. J Dermatolog Treat. 1994; 5:97–98.
   Google Scholar
• Abeck D, Brockow K, Mempel M, Fesq IL, Ring J. Treatment of acute exacerbated atopic eczema with emollient-antiseptic preparation using the ‘wet wrap’ (‘wet pyjama’) technique. Hautarzt. 1999; 50:418–421.
   PubMedGoogle Scholar
• Wolkerstorfer A, Visser RL, De Waard van der Spek FB, Mulder PG, Oranje AP. Efficacy and safety of wet-wrap dressings in children with severe atopic dermatitis: Influence of corticosteroid dilution. Br J Dermatol. 2000; 143:999–1004.
   PubMed Web of Science ®Google Scholar
• Tang WY. Diluted steroid facial wet wraps for childhood atopic eczema. Dermatology. 2000; 200:338–339.
   PubMedGoogle Scholar
• Pei AY, Chan HH, Ho KM. The effectiveness of wet wrap dressings using 0.1% mometasone furoate and 0.005% fluticasone propionate ointments in the treatment of moderate to severe atopic dermatitis in children. Pediatr Dermatol. 2001; 18:343–348.
   PubMedGoogle Scholar
• Schnopp C, Holtmann C, Stock S, Remling R, Foelster-holst R, Ring J, Topical steroids under wet-wrap dressings in atopic dermatitis – A vehicle-controlled trial. Dermatology. 2002; 204:56–59.
   PubMedGoogle Scholar
• Devillers AC, De Waard-van der Spek FB, Mulder PG, Oranje AP. Treatment of refractory atopic dermatitis using ‘wet-wrap’ dressings and diluted corticosteroids: Results of standardized treatment in both children and adults. Dermatology. 2002; 204:50–55.
   PubMedGoogle Scholar
• Mcgowan R, Tucker P, Joseph D, Wallace AM, Hughes I, Burrows NP, Short-term growth and bone turnover in children undergoing occlusive steroid (‘Wet-Wrap’) dressings for treatment of atopic eczema. J Dermatolog Treat. 2003; 14:149–152.
   PubMedGoogle Scholar
• Beattie PE, Lewis-jones MS. A pilot study on the use of wet wraps in infants with moderate atopic eczema. Clin Exp Dermatol. 2004; 29:348–353.
   PubMed Web of Science ®Google Scholar
• Foelster-holst R, Nagel F, Zoellner P, Spaeth D. Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis. Dermatology. 2006; 212:66–69.
   PubMedGoogle Scholar
• Hindley D, Galloway G, Murray J, Gardener L. A randomised study of ‘wet wraps’ versus conventional treatment for atopic eczema. Arch Dis Child. 2006; 91:164–168.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee SJ, Kim D, Bang D. The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2007; 21:1360–1368.
   PubMed Web of Science ®Google Scholar
• Hon KL, Wong KY, Cheung LK, Ha G, Lam MC, Leung TF, Efficacy and problems associated with using a wet-wrap garment for children with severe atopic dermatitis. J Dermatolog Treat. 2007; 18:301–305.
   PubMed Web of Science ®Google Scholar
• Geraldez MC, Carreon-gavino M, Hoppe G, Costales A. Diflucortolone valerate ointment with and without occlusion in lichen simplex chronicus. Int J Dermatol. 1989; 28:603–604.
   PubMed Web of Science ®Google Scholar
• Volden G. Successful treatment of therapy-resistant atopic dermatitis with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol Suppl (Stockh). 1992; 176:126–128.
   PubMedGoogle Scholar
• Gauger A, Mempel M, Schekatz A, Schäfer T, Ring J, Abeck D. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology. 2003; 207:15–21.
   PubMed Web of Science ®Google Scholar
• The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993; 186:23–31.
   PubMedGoogle Scholar
• Williams H. Wet wrap bandages for 4 weeks did not differ from topical ointments but increased skin infections in paediatric atopic eczema. Evid Based Med. 2006; 11:108.
   PubMedGoogle Scholar
• Devillers AC, Oranje AP. Efficacy and safety of ‘wet-wrap’ dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: A critical review of the literature. Br J Dermatol. 2006; 154:579–585.
   PubMed Web of Science ®Google Scholar
• Oranje AP, Devillers AC, Kunz B, Jones SL, DeRaeve L, Van Gysel D, Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature. J Eur Acad Dermatol Venereol. 2006; 20:1277–1286.
   PubMed Web of Science ®Google Scholar
• Brockow K, Grabenhorst P, Abeck D, Traupe B, Ring J, Hoppe U, Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus aureus-colonized atopic eczema. Dermatology. 1999; 199:231–236.
   PubMed Web of Science ®Google Scholar
• Levin C, Maibach HI. Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications. Am J Clin Dermatol. 2002; 3:141–147.
   PubMedGoogle Scholar
• Hartmann F, Lahmann JJ. Effect of the external use of triamcinolone acetonide under foil occlusive dressings on the plasma cortisol level and on the diurnal rhythm of plasma cortisol. Hautarzt. 1977; 28:198–202.
   PubMedGoogle Scholar
• Zhai H, Maibach HI. Effects of skin occlusion on percutaneous absorption: An overview. Skin Pharmacol Appl Skin Physiol. 2001; 14:1–10.
   PubMedGoogle Scholar
• Sneddon IB. [The noxious effects of steroids in local application. ] Bull Soc Fr Dermatol. Syphiligr. 1970; 77:670–672.
   Google Scholar
• Lagos BR, Maibach HI. Frequency of application of topical corticosteroids: An overview. Br J Dermatol. 1998; 139:763–766.
   PubMed Web of Science ®Google Scholar
• Green C, Colquitt JL, Kirby J, Davidson P. Topical corticosteroids for atopic eczema: Clinical and cost effectiveness of once-daily vs. more frequent use. Br J Dermatol. 2005; 152:130–141.
   PubMed Web of Science ®Google Scholar
• Kizu J, Ichihara W, Tomonaga E, Abe J, Watanabe T, Inoue T, Survey of mixing commercially available corticosteroid ointments with other ointments and the anti-inflammatory activity of the admixtures. Yakugaku Zasshi. 2004; 124:93–97.
   PubMedGoogle Scholar
• Gao HY, Li WAN, Po A. Topical formulations of fluocinolone acetonide. Are creams, gels and ointments bioequivalent and does dilution affect activity? Eur J Clin Pharmacol. 1994; 46:71–75.
   Google Scholar
• Ohtani M. Effect of the admixture of commercially available corticosteroid ointments and/or creams on their efficacy and side effects. Jpn J Health Care Sci. 2003; 29:1–10.
   Google Scholar
• Haigh JM. Dilution of topical corticosteroid formulations. Br J Pharm Practice. 1998; 10:60.
   Google Scholar
• Thaci D, Steinmeyer K, Ebelin ME, Scott G, Kaufmann R. Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure, is well tolerated, safe and effective. An open study. Dermatology. 2003; 207:37–42.
   PubMed Web of Science ®Google Scholar
• Beyeler M, Schmid-grendelmeier P, Hafner J. Significantly elevated systemic levels after occlusive application of topical tacrolimus in atopic dermatitis. Dermatology. 2006; 212:260–1.
   PubMedGoogle Scholar
• Gutman AB, Kligman AM, Sciacca J, James WD. Soak and smear: A standard technique revisited. Arch Dermatol. 2005; 141:1556–1559.
   PubMed Web of Science ®Google Scholar
• Ong PY, Ferdman RM, Dunaway T, Churgh JA, Inderlied CB. Down-regulation of atopic dermatitis-associated serum chemokines by wet-wrap treatment: A pilot study. Ann Allergy Asthma Immunol. 2008; 100:286–287.
   PubMed Web of Science ®Google Scholar
• Oranje AP, Verbeek R, Verzaal P, Haspels I, Prens E, Nagelkerken L. Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis. Br J Dermatol. 2009; 160:54–61.
   PubMedGoogle Scholar
• Page B. The benefits of Tubifast Garments in the management of atopic eczema. Br J Nurs. 2005; 14:289–292.
   PubMedGoogle Scholar